Stay updated on Frailty-guided Dosing in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.

Latest updates to the Frailty-guided Dosing in Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed, affecting only footer/navigation elements. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedA new site revision label 'Revision: v3.3.2' appears on the page. This seems to be a software/version update with no impact on study data or user workflows.SummaryDifference0.1%

- Check49 days agoChange DetectedThe record history shows a new revision entry (v3.3.1) added and an older revision (v3.2.0) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedA government funding status notice/banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check70 days agoChange DetectedThe update is a minor change to the record history presentation and does not affect study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

Stay in the know with updates to Frailty-guided Dosing in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.